Take a look at the Recent articles

Extended draf iib procedure in the treatment of unilateral frontal malignant tumor

Tengchin Wang

Department of otolaryngology, Tainan municipal hospital, Tainan City, Taiwan

E-mail : aa

DOI: 10.15761/ORR.1000103

Article
Article Info
Author Info
Figures & Data

Abstract

Draf III procedure can be applied for intra-frontal sinus malignant lesions conventionally. But in the confined, predominantly unilateral lesions, Draf IIb procedure is an ideal choice which cause less damage to the normal tissues. We report unilateral sinonasal malignant case with frontal involved. The frontal lesion was removed by Draf IIb procedure and the outcome is well without leaving severe sequelae.

Key Words

2021 Copyright OAT. All rights reserv

Draf IIb procedure

Introduction

Surgical resection is the main choice for sinonasal benign or malignant tumors. Traditionally, Draf III procedure can be performed to access the lesion inside the frontal sinus. In the case of confined, predominantly unilateral lesions, Draf IIb procedure provides wide access to the frontal sinus. This approach can be extended without destruction of the contralateral frontal sinus drainage pathway.

Case report

We report on a 52-year-old woman who suffered from right epistaxis, nasal obstruction and fetid odor discharge for 3 months. She received examination in our department, a papillomatous lesion with necrotic content was identified (Figure 1). Biopsy reports squamous cell carcinoma; SCC Antigen is elevating. Computed tomography displays a mass with central necrosis infiltrating the maxillary, ethmoid and frontal sinus; the medial maxillary wall is decayed and left frontal sinusitis is notable (Figure 2). We started operation by eradicating the tumor in the ethmoid, maxillary sinus. Once removing the tumor in the frontal recess, Draf IIb procedure was performed with an irrigated RAD curved burr (3.6 mm 55°, Medtronic). To drain co-existed contralateral frontal sinusitis and gaining adequate marging, we extended Draf IIb procedure by removing lower intersinus septum, the lesion inside the frontal sinus doesn’t infiltrate to the sinusal mucosa thus can be removed easily (Figure 3). There were no sequelas leaving in this patient. Post-operative followed-up exhibits no residual tumor, (Figure 4).

Figure 1. (a) Papillomatous lesion obstructs right nasal cavity (b)With necrotic material within the tumor.

Figure 2. Right nasal tumor with central necrosis infiltrates maxillary, ethmoid and frontal sinus (a,b) ; the medial maxillary wall is decayed (b. blue arrow).

Figure 3. Draf IIb.2 procedure includes removing tumor in the right frontal sinus and drain contralateral frontal sinusitis after lowing down intersinus septum (blue asterisk: suprabulla cell, yellow asterisk: right frontal sinus, green asterisk: left frontal sinus, blue arrow: intersinus septum).

Figure 4. There is no residual tumor in the maxillary, ethmoid (a) and frontal sinus (b).

Discussion and conclusion

In the case of confined, unilateral frontal lesions, less destructive, limited approaches, defined as extended Draf IIb, can be applied without disturbing the contralateral frontal sinus drainage pathway according to literature. Gotlib et al. have classified extended Draf IIb procedure into 3 subtypes [1]; Extended Draf IIb.2 (or mini-Lothrop) refers to Draf IIb procedure with removal of the lower intersinus septum. This technique is applicable for bilateral frontal lesions with one side limiting in frontal sinus or unilateral frontal sinus disease with intersinus septum devia­tion towards the lesion. It minimizes destruction of the contralateral frontal sinus drainage pathway when comparing to Draf III. The nasal septum can be kept intact as compared to Draf IIb.1 and Draf IIb.3 procedures.

Selected cases of unilateral frontal sinus malignant disease can also be safely and effectively managed using extended Draf IIb procedure. This technique not only offers an appropriate margin of resection, but also leads to less surgical duration and tissue trauma than draf III procedure.

References

  1. 1.Gotlib THeld-Zió?kowska MNiemczyk K(2015) Extended draf IIb procedures in the treatment of frontal sinus pathology. Clin Exp Otorhinolaryngol 8: 34-38. [crossref]

Editorial Information

Editor-in-Chief

Article Type

Case Report

Publication history

Received date: November 13, 2017
Accepted date: December 05, 2017
Published date: December 09, 2017

Copyright

©2017 Wang T. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Citation

Wang T (2017) Extended draf IIb procedure in the treatment of unilateral frontal malignant tumor Oncol Res Rev 1: doi: 10.15761/ORR.1000103

Corresponding author

Tengchin Wang

Department of otolaryngology, Tainan municipal hospital No.670, Chong de Rd, East Dist, Tainan City 701, Taiwan, Tel: +8862609926

Figure 1. (a) Papillomatous lesion obstructs right nasal cavity (b)With necrotic material within the tumor.

Figure 2. Right nasal tumor with central necrosis infiltrates maxillary, ethmoid and frontal sinus (a,b) ; the medial maxillary wall is decayed (b. blue arrow).

Figure 3. Draf IIb.2 procedure includes removing tumor in the right frontal sinus and drain contralateral frontal sinusitis after lowing down intersinus septum (blue asterisk: suprabulla cell, yellow asterisk: right frontal sinus, green asterisk: left frontal sinus, blue arrow: intersinus septum).

Figure 4. There is no residual tumor in the maxillary, ethmoid (a) and frontal sinus (b).